US OKs Kodak's first mammography CAD (computer-aided detection) technology:
This article was originally published in Clinica
Eastman Kodak has received FDA clearance to sell its mammography computer-aided detection (CAD) system in the US. The product is Kodak's first CAD system developed for breast cancer detection and will be available immediately, the company said. CAD is a digital software technology designed to aid the detection of early stage breast cancer and is used as an adjunct to mammography. Kodak said that results from a clinical trial submitted to the FDA found that 39.4% of breast cancers that are missed could have been detected 14.8 months earlier using its CAD technology. Approximately 95% of patient mammography images in the US are still captured on X-ray film, the company said.
You may also be interested in...
Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.
The UK biotech's CEO tells Scrip that Izana's objective is to treat rapidly deteriorating COVID-19 patients before ICU admission and prior to ventilation.
Exclusive: HBW Insight speaks to HRA Pharma CEO David Wright about the company's plans to become a top-10 global OTC player. Wright reveals that HRA is about to enter Latin America, beginning with Mexico and Brazil, and is currently looking at at least two significant acquisitions to ramp up its expansion plans in the coming months.